MedPath

AGAROL WITH SENNOSIDES

AGAROL WITH SENNOSIDES

Discontinued
DIN Number

02240031

Drug Class

Human

Market Date

Jun 30, 1999

Company
HC

numark laboratories, inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02240031
AIG Number0107819001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AB06 SENNA GLYCOSIDES
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SENNOSIDESActive
Strength: 25 MG / 15 ML
Monograph: SENNOSIDES

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.